Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Clinical trial NCT00760435 · COMPLETED
Trial details
- NCT number
- NCT00760435
- Sponsor
- University of California, San Diego
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-10-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.